Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
c-KIT
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
dasatinib
/ Generic mfg.
Turalio
(pexidartinib) / Daiichi Sankyo
dovitinib
(TKI258) / Novartis, Oncoheroes
ganetespib
(ADX-1612) / Aldeyra
motesanib
(AMG 706) / Takeda
vatalanib
(PTK787) / Novartis, Bayer
Balversa
(erdafitinib) / J&J
Fotivda
(tivozanib) / Kyowa Kirin, Jazz, LG Chem
Iclusig
(ponatinib) / Takeda, Otsuka
chiauranib
(CS 2164) / Chipscreen
tandutinib
(MLN518) / Takeda
XL820
/ Exelixis
sitravatinib
(MGCD516) / BeiGene
